), an agriculture chemicals producer, reported its financial
results for the fourth quarter and year 2012 on Feb 6, 2013. In
2012, earnings per share, excluding restructuring and impairment
charges, came in at $22.30, up 15% from $19.36 reported in 2011.
BASF SE (BASFY): Free Stock Analysis Report
GRUMA SA-ADR B (GMK): Free Stock Analysis
MONSANTO CO-NEW (MON): Free Stock Analysis
SYNGENTA AG-ADR (SYT): Free Stock Analysis
To read this article on Zacks.com click here.
In fourth quarter 2012, sales increased 12% to $3.2 billion as
North America and Latin America witnessed healthy performance
with sales growing 28% and 17% year over year, respectively. The
results were partially offset by a 7% decline in Europe, Africa
and the Middle East and 3% in Asia Pacific.
In 2012, sales grew 7% (10% on constant currency rates) to $14.2
billion on the back of higher sales volume and healthy price
Gross profits in 2012 grew 7.6% while margins stood at 49.2%
compared with 49.0% in 2011. Operating expenses, including
G&A, R&D and marketing and distribution, grew 5.6% in
2012 and represented 31.2% of total revenue. Operating margin was
16.1% compared with 15.5% in 2011.
Exiting 2012, the company's cash and cash equivalents stood at
$1.6 billion, down 4.0% year over year. Financial debt and other
non-current liabilities were $2.5 billion compared with $2.4
billion in 2011.
Cash generated from operating activities in 2012 grew 27.4% and
came in at $1.4 billion. Capital spending in the year was $508
million, up 6.1% year over year.
The same day, management announced its expansion plans for
investing roughly $77 million in its corn seed protection
facility in Brazil. The capacity is expected to increase four
times to 1.6 million bags by 2015. This investment was
particularly planned to tap the expected increase in corn
production in Brazil which is expected to double by 2020.
Sygenta AG currently holds a Zacks Rank #1 (Strong Buy). Other
stocks to watch out for in the industry are
Gruma S.A.B. de CV
), each with a Zacks Rank #1 (Strong Buy) and
), with a Zacks Rank #2 (Buy)